MedSphere International, Inc. 5t0(k) Premarket Notification
MSI S-500 RF Generator
rrr
APR ~ 22 K033 Oey
Section E - 510(k) Summary
Submitted by:
MedSphere International, Inc.
48511 Warm Springs Blvd., Suite 212, Fremont, CA 94539
Tel: 510-656-8232 Fax: 510-656-8816
Contact Person:
Eric Kao, Vice President of Quality and Regulatory Affairs
Date Summary Prepared:
December 12, 2003
Name of the Device:
Trade / Proprietary Name: MSI S-500 RF Generator
Common / usual Name: Electrosurgical Generator and Accessories
Classification Name: Electrosurgical cutting and coagulation device (21CFR878.4400)
Predicate Devices:
Somnus Model 225 Electro Surgical Generator (K963772)
Description:
MSI S-500 RF Generator
Statement of Intended Use:
MS! S-500 RF Generator is intended for coagulation of soft tissue.
This device is intended for use by qualified medical personnel trained in the use of
electrosurgery.
Comparison to Predicate Devices:
MSI S-500 RF Generator has been compared to previously 510(k) cleared device with
respect to intended use and technological characteristics. Performance testing was done
to validate its intended use. The comparison and performance testing results in this
510(k) notification shows MSI S-500 RF Generator is substantially equivalent to predicate
device and is safe and effective in its intended use.
Page E-1

aa
fo DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
(ME
“oe . Food and Drug Administration
APR = 2 2004 9200 Corporate Boulevard
Rockville MD 20850
Mr. Eric Kao
Vice President of Quality and Regulatory Affairs
Medsphere International, Inc.
48511 Warm Springs Boulevard, Suite 212
Fremont, California 94539
Re: K033888
Trade/Device Name: MSI S-500 RF Generator
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: II
Product Code: GEI /
Dated: March 2, 2004
Received: March 4, 2004
Dear Mr. Kao:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class II] (PMA), it
/ may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. Eric Kao
: This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
, contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled,
“Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
. { cetia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure

MedSphere International, inc. 510(k) Premarket Notification
MSI S-500 RF Generator
Section D - Statement of Indications for Use
kK 03338
ee nnn
Indications for Use
Applicant: MedSphere International, Inc.
48511 Warm Springs Blvd., Suite 212, Fremont, CA 94539
510(k) Number (if known):
Device Name: MSI S-500 RF Generator
Indications For Use: Indicated for coagulation of soft tissue
These devices are intended for use by qualified medical personnel
trained in the use of electrosurgery. |
(PLEASE DO NOT WRITE BELOW THIS LINE —- CONTINUE ON ANOTHER PAGE, IF
NEEDED)
(Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of General, Restorative,
and Neurological Devices
i
K6 2988 |
510(k) Number__4.¢ 2399 5 |
|
Prescription Use 4 OR Over-the-Counter Use |
(Per 21 CFR 801.109) |
|
}
(Optional format 1-2-06)
Page D-1

